how many people are on glp-1 drugs in the us Antagonists Increase Plan Drug Spend - What's Next The obesity rate in the

Many plans specifically exclude weight loss medications regardless of FDA approval

2 | Health systems partner for data insights on GLP-1s

These advanced therapies often carry premium pricing, contributing to market growth even as generics and biosimilars enter the market

Nielsen CK, Palsson T, Jensen B, Johansen N, Pedersen M, Forman J, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 97.Harikumar K.G., Wootten D., Pinon D.I., Koole C., Ball A.M., Furness S.G., Graham B., Dong M., Christopoulos A., Miller L.J., et al

Subject to Lilly USA, LLCs (Lilly) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lillys sole discretion, without notice, and for any reason